AI Insight
This article reviews a decade of progress in spatially resolved transcriptomic technologies, which enable researchers to map gene expression patterns within tissue structures while preserving spatial information. The field has advanced through collaborative development between academic researchers and industry partners, creating increasingly sophisticated tools for visualizing where specific genes are active within intact tissues. These technologies have significantly improved understanding of both normal developmental processes and disease mechanisms by revealing how gene expression varies across different tissue regions.
Why it matters
Spatial transcriptomics bridges a critical gap between traditional gene expression analysis and tissue architecture, enabling more precise identification of disease markers and therapeutic targets. The ongoing partnership between academia and industry suggests continued innovation that could accelerate biomedical research and improve diagnostic approaches for complex diseases.
Understand the Science
Nature, Published online: 21 July 2026; doi:10.1038/d41586-026-02212-1
Spatially resolved transcriptomic technologies continue to enhance understanding of development and disease through a feedback loop involving academia and industry.